These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3242655)

  • 1. Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus.
    Denburg SD; Carbotte RM; Long AA; Denburg JA
    Brain Behav Immun; 1988 Sep; 2(3):222-34. PubMed ID: 3242655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus.
    Long AA; Denburg SD; Carbotte RM; Singal DP; Denburg JA
    Ann Rheum Dis; 1990 Apr; 49(4):249-53. PubMed ID: 2339907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte antigens in neuropsychiatric systemic lupus erythematosus. Relationship of lymphocyte antibody specificities to clinical disease.
    Denburg SD; Behmann SA; Carbotte RM; Denburg JA
    Arthritis Rheum; 1994 Mar; 37(3):369-75. PubMed ID: 8129792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lymphocytotoxic antibodies in neuropsychiatric lupus: a serial study.
    Temesvari P; Denburg J; Denburg S; Carbotte R; Bensen W; Singal D
    Clin Immunol Immunopathol; 1983 Aug; 28(2):243-51. PubMed ID: 6872362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus.
    Szmyrka M; Pokryszko-Dragan A; Słotwiński K; Gruszka E; Korman L; Podemski R; Wiland P
    Adv Clin Exp Med; 2019 Feb; 28(2):185-192. PubMed ID: 29963787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment and autoantibodies in systemic lupus erythematosus.
    Hanly JG; Walsh NM; Fisk JD; Eastwood B; Hong C; Sherwood G; Jones JV; Jones E; Elkon K
    Br J Rheumatol; 1993 Apr; 32(4):291-6. PubMed ID: 8461922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus.
    Hanly JG; Robichaud J; Fisk JD
    J Rheumatol; 2006 Aug; 33(8):1553-8. PubMed ID: 16881112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment in systemic lupus erythematosus and neuropsychiatric systemic lupus erythematosus: a population-based neuropsychological study.
    Loukkola J; Laine M; Ainiala H; Peltola J; Metsänoja R; Auvinen A; Hietaharju A
    J Clin Exp Neuropsychol; 2003 Feb; 25(1):145-51. PubMed ID: 12607179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between lymphocytotoxic antibodies, anti-DNA antibodies and a common anti-DNA antibody idiotype PR4 in patients with systemic lupus erythematosus, their relatives and spouses.
    Le Page SH; Williams W; Parkhouse D; Cambridge G; MacKenzie L; Lydyard PM; Isenberg DA
    Clin Exp Immunol; 1989 Sep; 77(3):314-8. PubMed ID: 2805403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus.
    Harrison MJ; Ravdin LD; Lockshin MD
    Arthritis Rheum; 2006 Aug; 54(8):2515-22. PubMed ID: 16868972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytotoxic antibodies in systemic lupus erythematosus and clinically related diseases.
    Schocket AL; Kohler PF
    Arthritis Rheum; 1979 Oct; 22(10):1060-3. PubMed ID: 39565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.
    Kozora E; Erkan D; Zhang L; Zimmerman R; Ramon G; Ulug AM; Lockshin MD
    Clin Exp Rheumatol; 2014; 32(1):34-40. PubMed ID: 24021640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphocytotoxic antibodies in SLE: a review of the literature.
    Osman C; Swaak AJ
    Clin Rheumatol; 1994 Mar; 13(1):21-7. PubMed ID: 8187440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive Impairment in Patients With Neuropsychiatric and Non-neuropsychiatric Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis.
    Zabala A; Salgueiro M; Sáez-Atxukarro O; Ballesteros J; Ruiz-Irastorza G; Segarra R
    J Int Neuropsychol Soc; 2018 Jul; 24(6):629-639. PubMed ID: 29553037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocytotoxic antibody in Sjögren's syndrome.
    Ichikawa Y; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1980 Jul; 5(3):329-37. PubMed ID: 7222123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of soluble antigen-induced T cell proliferation by warm-reactive antibodies to activated T cells in systemic lupus erythematosus.
    Yamada A; Winfield JB
    J Clin Invest; 1984 Dec; 74(6):1948-60. PubMed ID: 6210306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytotoxic antibodies in systemic lupus erythematosus patients and their relatives: reactivity with the HLA antigenic molecular complex.
    Messner RP; De Horatius R; Ferrone S
    Arthritis Rheum; 1980 Mar; 23(3):265-72. PubMed ID: 6153898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-N-methyl-D-aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus.
    Lapteva L; Nowak M; Yarboro CH; Takada K; Roebuck-Spencer T; Weickert T; Bleiberg J; Rosenstein D; Pao M; Patronas N; Steele S; Manzano M; van der Veen JW; Lipsky PE; Marenco S; Wesley R; Volpe B; Diamond B; Illei GG
    Arthritis Rheum; 2006 Aug; 54(8):2505-14. PubMed ID: 16868971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological assessment in systemic lupus erythematosus patients: clinical usefulness of first-choice diagnostic tests in detecting cognitive impairment and preliminary diagnosis of neuropsychiatric lupus.
    Nowicka-Sauer K; Czuszynska Z; Smolenska Z; Siebert J
    Clin Exp Rheumatol; 2011; 29(2):299-306. PubMed ID: 21418780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.